chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Systemic: Fainting / Unresponsive-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Hypotension-Severe, Additional Details: light headed started to fall sweating called 911 paramedics took to hospital as blood pressure too long could not leave her
This spontaneous report as received from a other health professional refers to unspecified number of patient of unknown age and gender. Licensed nurse reported that since 17-JUL-2014, improperly stored (Merck) VARIVAX (dose, strength, route and lot number were not reported) was dispensed to patients. No adverse effects were noted. Follow up information has been received from Licensed Practical Nurse. Nurse did not have the information (patient identifiers, lot number, expiration date or dates of vaccine administration) available. Follow up information has been received from Licensed Practical Nurse referring to a 15 month old patient of unknown gender. On 04-SEP-2014 the patient was vaccinated with improperly stored (Merck) VARIVAX lot # J013905, expiration date 30-OCT-2015. This is one of several reports received from the same reporter. Additional information is not expected because all follow ups requested to complete the case were received.
Flushing/sweating. Vitals wnl/stable, given water and orange juice.
Reports itchy hands day after vaccine (07/24/15). On 07/25/15 reports progression of symptoms: entire body itching for 30-60 min then went away. Aching in joints, painful to swallow/sore throat. Currently taking antihistamine.
Patient came to emergency room complaining of pain, intense, severe locating in epigastric area and diffuse all over the abdomen associated with nausea and vomiting.  While admitted it was identified that Pt had Subacute thrombosis of the main trunk of the superior mesenteric artery with no flow distal, 3 cm from the ostium with no flow identified in the right-sided branches or jejunal branches. MD thinks is due to Moderna Vaccine as Pt has no history or clots.
Patient started having itching on back and shoulder the day after vaccination. Shingles rash developed within the next few days. Pain and increased blood pressure caused patient to seek medical attention at local hospital.
Hives on face. Itching. I took one Benadryl at about 1pm and the itching stopped after about 1/2 hour.  Itching started again about 5 hours later so I took two Benadryls. The next morning the hives were gone and no more itching.
Patient's wife called the evening after receiving the immunizations that afternoon. She said that he had a high fever and severe weakness. The right arm was slightly swollen and had a 3 inch red circle. Pharmacist on duty said to contact his doctor if he did not feel better by next day.
Pain at injection site for 1 month and still going. Pain, stiffness, hardness when sleeping on that side. Popping noise in shoulder area. Went to PCP doctor. Told to stretch and ice, which i have been doing. Has not gone away.
Child came into clinic one day after given immunizations with symptoms of vomiting, fever, rash. Patient was advised to go to ER. In ER patient was diagnosed with UTI.
Pt recvd vax 10JUN92 & 1 wk p/vax devel tingling in one hand; 2 wks p/vax devel tingling in both hands;
Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 06-Feb-2022; Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 06-Feb-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 06-Feb-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 06-Feb-2022) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Feb-2022 at 10:25 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 06-Feb-2022 at 10:25 AM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 06-Feb-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 06-Feb-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 06-Feb-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 06-Feb-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.    Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.
My heart rate increased after 2nd shot; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (My heart rate increased after 2nd shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEART RATE INCREASED (My heart rate increased after 2nd shot). At the time of the report, HEART RATE INCREASED (My heart rate increased after 2nd shot) outcome was unknown.            No concomitant medications were reported.  No treatment information was provided.
Initial information has been received from a physician and follow up information has been received from a nurse concerning a female patient between the ages of 11 and 19 who was vaccinated IM with a dose of Gardasil. It was reported that the patient sat for a minute (after receiving the injection) and when she got up to leave she fainted in the hallway. Her outcome was not reported. The physician reported that lot numbers were not available, however, the physician will forward other information including the lot numbers. Additional information has been requested.This is in follow-up to report (s) previously submitted on 6/14/2007. Follow-up information has been received from a healthcare professional concerning the 14 year old female student who on 26-Apr-2007 at 2:15 p.m. received her first IM dose of GARDASIL, LOT # 657617/0384u. At 2:15 p.m. the patient experienced dizziness (also reported as within 5 minutes of receiving immunization patient excperienced dizziness). The patient laid down on the exam table and was "within normal limits after 10 minutes on the table". No treatment was necessary. Addional information is not expected.
Pt recvd a series of 3 Engerix-B on 5DEC89, 11JAN90 & 19JUN90; subsequently tested for Hep B antibodies & found not to have converted;
I was very sleepy and tired. I had swollen and pain where the injection site.  A week later, I was still very fatigue.  I had sneezing, nose running, and diarrhea. My lymph nodes in my face was a little sore and swollen.
Received Tdap, influenza and PNEUMOVAX vaccines 01/06/09. Pt called clinic 01/13/09 to report that on 01/07/09, she had experienced onset "severe chills" - requiring VALIUM to relive after one hour. In addition - reports weakness, inability to ambulate by self without walker X several days. Other sx: Voice hoarseness, blurred vision, increased fatigue and somnolence. By 01/13/09 - Ambulating with walker unassisted. Vision WNL; fatigue ongoing.
pt immed lost conscious for about 20min during which time MD was trying to revive pt;arm became very painful & cannot use arm d/t severe pain;pain is still severe & cannot use arm;MD told pt to apply warm compress & take APAP;
Patient fainted approximately 5 minutes after receiving the vaccine and was unconscious for about 30 seconds. To note, patient hadn't eaten before receiving the vaccine. We had her seat for 30 minutes and gave her orange juice and water.
Soreness in the arms; Nausea; Headache; Chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness in the arms), NAUSEA (Nausea), HEADACHE (Headache), CHILLS (Chills) and PYREXIA (Fever) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Soreness in the arms), NAUSEA (Nausea), HEADACHE (Headache), CHILLS (Chills) and PYREXIA (Fever). At the time of the report, PAIN IN EXTREMITY (Soreness in the arms), NAUSEA (Nausea), HEADACHE (Headache), CHILLS (Chills) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient was having nausea, headache, fever, chills, and soreness in their arms.  No Concomitant product use was reported. No treatment information was provided.
18JAN96 pt recv vax & reported 2hr p/vax nausea, weakness, diarrhea, rapid heart rate, diff breathing, numbness in legs, unable to walk 6-7 hr;
Narrative: Covid+, Moderna #3, general unwellness, feeling of fevers at home, as well as headache, night sweats, traveled by plane, low oxygen sats, acute hypoxemic respiratory failure/ Dex and remdesivir, d/c home
This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching on the Injection Site), VACCINATION SITE INDURATION (Hardness on the Injection Site), VACCINATION SITE PAIN (Soreness on the Injection Site), AXILLARY PAIN (Sore Armpit) and VACCINATION SITE ERYTHEMA (Red Injection Site) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. No Medical History information was reported. On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced VACCINATION SITE PAIN (Soreness on the Injection Site). On 10-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Itching on the Injection Site), VACCINATION SITE INDURATION (Hardness on the Injection Site), AXILLARY PAIN (Sore Armpit) and VACCINATION SITE ERYTHEMA (Red Injection Site). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 06-Mar-2021, VACCINATION SITE PAIN (Soreness on the Injection Site) had resolved. At the time of the report, VACCINATION SITE PRURITUS (Itching on the Injection Site), VACCINATION SITE INDURATION (Hardness on the Injection Site), AXILLARY PAIN (Sore Armpit) and VACCINATION SITE ERYTHEMA (Red Injection Site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications were not reported. Reporter did not allow further contact.
developed 3 DVT's (deep vein thrombosis) on my legs; I almost died; blood clots; broke her foot; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 69 year-old female patient received bnt162b2 (BNT162B2), administration date 19Mar2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation; tamoxifen (TAMOXIFEN) (Batch/Lot number: unknown). The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1, MANUFACTURER UNKNOWN), for COVID-19 immunization. The following information was reported: DEEP VEIN THROMBOSIS (medically significant) with onset 27Mar2021, outcome "unknown", described as "developed 3 DVT's (deep vein thrombosis) on my legs"; NEAR DEATH EXPERIENCE (medically significant) with onset 2021, outcome "unknown", described as "I almost died"; THROMBOSIS (medically significant) with onset 2021, outcome "unknown", described as "blood clots"; FOOT FRACTURE (medically significant) with onset 2021, outcome "unknown", described as "broke her foot". Patient got in a knee high boot from 05Jan2021 to 24Mar2021. She was not supposed to be walking in the boot but she did. During this time she was also on tamoxifen. She should've gotten off this medication immediately, but her oncologist did not let her know she should have done so and she had received the second dose, while she was on the knee high boot and taking tamoxifen. On 27Mar2021, patient developed 3 DVT's (deep vein thrombosis) on her legs. She was scheduled on 14Dec2021 to receive booster dose. She spoke to a pharmacist and he told her she could develop blood cloths from this vaccine two weeks after vaccination, other people had told her the same (that there was information that could develop blood cloths after vaccination). Her doctor told her she should get the booster dose and she was scared about developing blood cloths again. She almost died. Patient broke her foot and was on tamoxifen at the time. The doctor told her that she should have been off the tamoxifen because if a person wasn't moving around that product could cause blood clots and he thought that was why she got the blood clot, not because of the vaccine. It was noted that after this happened within 2 weeks of the second dose that was given 19Mar2021. It was also told to her that after the second dose, it was rare, but a person could get a blood clot, which was what happened to her. Her doctor said that probably this was from the tamoxifen, the blood clot. The events "developed 3 dvt's (deep vein thrombosis) on my legs" and "blood clots" were evaluated at the physician office visit. The action taken for tamoxifen was unknown.  The lot number for bnt162b2 was not provided and will be requested during follow up.
The caller mentioned that they are both feeling better, no longer coughing, no sore throat or headache like they were having; The caller mentioned that they are both feeling better, no longer coughing, no sore throat or headache like they were having; The caller mentioned that they are both feeling better, no longer coughing, no sore throat or headache like they were having; States she had no energy. She was in bed really sick; States she had no energy. She was in bed really sick; still tired; she still has Covid because she feels stuffy; Covid 19 after three doses of Pfizer Covid Vaccine; Covid 19 after three doses of Pfizer Covid Vaccine; Booster; This is a spontaneous report received from contactable reporter(s) (Other HCP) from product quality group. The reporter is the patient.  A 63 year-old female patient received bnt162b2 (BNT162B2), administration date 11Oct2021 (Lot number: FH8020) at the age of 63 years as dose 3, (booster) single, administration date 16Mar2021 (Lot number: FN6199) as dose 1, single and administration date 06Apr2021 (Lot number: FR8737) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: IMMUNISATION (medically significant) with onset 11Oct2021, outcome "unknown", described as "Booster"; VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 15Jan2022, outcome "unknown" and all described as "Covid 19 after three doses of Pfizer Covid Vaccine"; COUGH (non-serious), OROPHARYNGEAL PAIN (non-serious), HEADACHE (non-serious), outcome "recovered" and all described as "The caller mentioned that they are both feeling better, no longer coughing, no sore throat or headache like they were having"; ASTHENIA (non-serious), ILLNESS (non-serious), outcome "recovered" and all described as "States she had no energy. She was in bed really sick"; FATIGUE (non-serious), outcome "not recovered", described as "still tired"; NASAL CONGESTION (non-serious), outcome "not recovered", described as "she still has Covid because she feels stuffy". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (15Jan2022) positive. Therapeutic measures were taken as a result of vaccination failure, covid-19.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of event cannot be totally excluded.
Received flu shot at lunch time and it was administered very high in my left arm rather than in the muscle as I was accustomed to. By 8:00 PM  any movement of my arm became very painful. At times I used my right arm to pick up my left arm because the act of moving it on its own was too painful.  After about two weeks with no improvement, I consulted my doctor.  He prescribed prednisone and I did get relief while I was on it, but then returned to extreme pain in the deltoid muscle with movement.  After Thanksgiving he suggested another treatment of prednisone and again I did get some relief.  Although, I have been able to accomplish more movement with the arm, I am still experiencing pain with movement in the deltoid muscle.  I am currently seeing an orthopaedic doctor and getting physical therapy.  However, the pain in the deltoid muscle when I move the arm continues.
This spontaneous report as received from a physician via a company representative refers to a male patient of unknown age. On an unknown date the patient was vaccinated with a dose of GARDASIL (intramuscular, dose, units, anatomical location, lot  number were not reported). On an unknown date the patient almost passed out. The reporter stated that the patient did not technically faint. The patient did not seek medical attention. The outcome of adverse event was not reported. The relatedness between adverse event and GARDASIL was not reported. Additional information has been requested.
With administration of Janssen vaccine pt reports headache and blurred vision. Pt was anxious about vaccine. Pt then proceeded after waiting period to Clinic office(next door) for Tdap as last dose was 2011. She received Tdap there per pt request in the same arm as the Janssen was given and immediately vomited after administration and became shaky, she returned to office where her BP was taken 114/72 and HR 70's. She was given some water, apple juice, and applesauce and remained seated with a fan for 30-45 min. She was encouraged to seek medical care if any increase or cont. s/s after she departed the office. She left because she needed to study and felt well enough to go home. She states about two hours later she ended up going to the ER at Hospital for continuous dry heaves. She had a negative pregnancy test and was given IV fluids and antiemetics and discharged about 2 hours later on 7/28/22. Since vaccination she has cont. to have decreased appetite, nausea and vomiting of mostly all fluids and solids she has attempted to eat. Shaky feeling, occasional blurred vision, headache, abdominal pain (from hunger and heaving) as well as now "mensural" type cramping (menses started 8/3/22-normal amount of bleeding). Reports arm site was sore but is better, no issues with that. Went to Dr today at Clinic d/t cont. n/v and was given a steroid shot and antiemetic ordered, no other labs ordered. Denies petechia, extremity pain or cramping
Moderna COVID 19 Vaccination EUA  Patient was admitted for a planned total knee which had no complications
Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Mar-2021, the patient experienced FATIGUE (Fatigue). At the time of the report, FATIGUE (Fatigue) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Mar-2021, Blood glucose: high (High) Increased BSL.         No concomitant medications reported. No treatment information provided.    This case was linked to MOD-2021-085901 (Patient Link).
dehydration; pelvic pain; could not sleep; couldn't eat; diarrhea/Diarrhea Symptoms; This case was reported by a consumer via call center representative and described the occurrence of diarrhea in a 71-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concomitant products included Herpes zoster (Shingrix).   On 9th April 2019, the patient received the 2nd dose of Shingrix (intramuscular). On 20th April 2019, 11 days after receiving Shingrix, the patient experienced diarrhea, pelvic pain, insomnia and appetite absent. On 25th April 2019, the patient experienced dehydration. On an unknown date, the outcome of the diarrhea and pelvic pain were not recovered/not resolved and the outcome of the dehydration, insomnia and appetite absent were unknown.   It was unknown if the reporter considered the diarrhea, dehydration, pelvic pain, insomnia and appetite absent to be related to Shingrix.  Additional details were provided as follows: The patient received 2nd dose of Shingrix on left arm. The patient experienced diarrhea symptoms and on 1st day she had diarrhea over 14 times and she couldn't sleep and she stopped eating. The patient was also dehydrated. On 27th April 2019, the patient felt like she could control her bowels. On 27th April 2019, the patient had her bowel tests and results are pending. The patient had colonoscopy to determine if her symptoms are related to the vaccine or to another condition. Till the time of reporting, the patient still had diarrhea and pain in pelvic area.
Admitted 8/6, 2021 after tested COVID + .  Respiratory deterioration continued until mechanical ventilation required 8/10.  CRT also required.  Developed ST elevated MI.  Compassionately extubated and expired on 8/16/2021.
My Father had been in his usual state of health when he received his first Pfizer Covid-19 shot on 1/12/2021 and his second dose on 2/2/2021.  He complained of being tired and chills on 1/13/2021 and again on 1/20/2021.  He was diagnosed with a UTI and placed on antibiotics on 1/27/2021.  After the second covid-19 shot on 2/2/2021 my father had a change in his condition on 2/4/2021.  He became very lethargic, more confused and unable to speak and was send to the Hospital.    He spent from 2/4/2021 to 2/12/2021  in the hospital being treated for a UTI and also was said to have had a Transient Ischemic Attack.  He went to a rehab facility for Physical Therapy from 2/12/2021 to 2/19/2021 after which he returned to the Assisted Living Facility.  He had another episode of lethargy/unresponsiveness on 2/26/2021 and was once again sent to the hospital where they did not show any new findings.  He spent a few days in the hospital before returning to his facility where he continued to have periodic episodes of increased lethargy/confusion and decreased eating.  He was placed on Hospice and passed away on March 29th.
NO signs and symptoms of any distress.  H1N1 flu mist given 22 days after seasonal flu mist.
Brought on exacerbation of the PMD which had gotten better over the past 5 weeks, to a point where all progress made had been lost.  Lasted 2.5 days so far
Fever of at least 102 for three days. Flu-like symptoms. Itchy skin.
Pt experienced local reaction redness, swelling and general malaise. The pt also experienced headaches. Subsequently the pt recovered.
inner ear affected-ataxia, nausea, vomit, inability to stand;some diarrhea x 2 days;Meclizine prescribed by PMD;